US 8017762
Modified iRNA agents
granted A61PA61P35/00
Quick answer
US patent 8017762 (Modified iRNA agents) held by Alnylam Pharmaceuticals, Inc. expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61P, A61P35/00